The page is the record's research on the issuer — no analyst, no rating, no view. # Can-Fite BioPharma Ltd. (NYSE: CANF) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing Can-Fite BioPharma Ltd. is listed on the NYSE under ticker CANF, ISIN US13471N4097. The record holds no LEI for the issuer. Its security type is recorded as non-operating entity type (other), its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is Israel. Its listing status is listed, not halted. ## The disclosure read The record holds 76 filings in the window 2025-11-08 to 2026-11-08, across 54 filing days. Of these, 45 are results, 14 are regulatory filings, 9 are directors' dealings and 8 are prospectuses. The median gap between filing days is 5 days. The latest filing is a results filing dated 2026-11-02, 6 days before the record date of 2026-11-08. On the NYSE, the median cadence gap is 6.0 days, the median filings count is 64.0 and the median latency is 4.0 days. In the sector 2834 Pharmaceutical Preparations, the median cadence gap is 6.0 days, the median filings count is 63.0 and the median latency is 4.0 days. The issuer's cadence gap of 5 days is below both medians, its filings count of 76 is above both, and its latency of 6 days is above both. ## Auditor The auditor of record is not on the record, because the latest annual report cover carries no auditor name tag. Its location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change events. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because exchange tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter was as of 2026-11-04. ## Coverage The issuer's investor-relations page names 3 research houses: Alliance Global Partners, Dawson James and H.C. Wainwright. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001536196.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NYSE/CANF (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://ir.canfite.com/news-events/research (coverage) - https://mcp.us-cm-kg.ai/record/NYSE/CANF (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NYSE/CANF · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp